Index S&P 500
P/E -
EPS (ttm) -0.45
Insider Own 0.72%
Shs Outstand 507.63M
Perf Week 1.74%
Market Cap 21.71B
Forward P/E 13.31
EPS next Y 3.21
Insider Trans -1.73%
Shs Float 504.32M
Perf Month 2.84%
Income -226.00M
PEG -
EPS next Q 0.61
Inst Own 91.55%
Short Float 1.62%
Perf Quarter 10.55%
Sales 14.95B
P/S 1.45
EPS this Y 11.56%
Inst Trans 0.70%
Short Ratio 2.16
Perf Half Y 14.49%
Book/sh 16.55
P/B 2.58
EPS next Y 10.68%
ROA -0.11%
Short Interest 8.18M
Perf Year 7.25%
Cash/sh 6.30
P/C 6.79
EPS next 5Y 4.07%
ROE -0.44%
52W Range 31.01 - 50.21
Perf YTD 10.55%
Dividend Est. 1.22 (2.85%)
P/FCF 21.00
EPS past 5Y -
ROI -1.13%
52W High -14.88%
Beta 0.62
Dividend TTM 1.16 (2.71%)
Quick Ratio 1.04
Sales past 5Y 6.04%
Gross Margin 36.67%
52W Low 37.83%
ATR (14) 0.85
Dividend Ex-Date Feb 29, 2024
Current Ratio 1.48
EPS Y/Y TTM 90.76%
Oper. Margin 9.63%
RSI (14) 58.81
Volatility 1.74% 2.00%
Employees 60000
Debt/Eq 1.71
Sales Y/Y TTM -1.09%
Profit Margin -1.51%
Recom 2.47
Target Price 44.67
Option/Short Yes / Yes
LT Debt/Eq 1.38
EPS Q/Q 39.78%
Payout -
Rel Volume 0.97
Prev Close 42.69
Sales Surprise 2.07%
EPS Surprise 1.80%
Sales Q/Q -0.05%
Earnings Feb 08 BMO
Avg Volume 3.79M
Price 42.74
SMA20 1.15%
SMA50 4.65%
SMA200 7.19%
Trades
Volume 3,694,328
Change 0.12%
Date
Action
Analyst
Rating Change
Price Target Change
May-30-23 Resumed
Morgan Stanley
Equal-Weight
$45
Mar-29-23 Initiated
UBS
Neutral
$43
Jan-06-23 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$55
Jan-05-23 Downgrade
Raymond James
Outperform → Mkt Perform
Jan-03-23 Downgrade
BofA Securities
Buy → Neutral
$66 → $55
Dec-19-22 Downgrade
JP Morgan
Overweight → Neutral
$68 → $55
Dec-15-22 Downgrade
Deutsche Bank
Buy → Hold
$69 → $51
Dec-12-22 Downgrade
Citigroup
Buy → Neutral
$64 → $58
Oct-18-22 Initiated
Barclays
Overweight
$64
Oct-12-22 Initiated
Jefferies
Hold
$62
Jun-24-22 Downgrade
Wells Fargo
Overweight → Equal Weight
$71
Apr-04-22 Downgrade
Goldman
Neutral → Sell
$88 → $77
Mar-02-22 Resumed
BofA Securities
Buy
$100
Feb-18-22 Reiterated
Wells Fargo
Overweight
$95 → $93
Feb-18-22 Reiterated
UBS
Neutral
$88 → $91
Feb-18-22 Reiterated
Stifel
Buy
$90 → $91
Feb-18-22 Reiterated
Raymond James
Outperform
$99 → $96
Feb-18-22 Reiterated
Morgan Stanley
Overweight
$110 → $105
Feb-18-22 Reiterated
KeyBanc Capital Markets
Overweight
$98 → $95
Feb-11-22 Initiated
Goldman
Neutral
$91
Show Previous Ratings
Mar-28-24 03:24PM
Mar-27-24 09:00AM
Mar-26-24 05:00PM
Mar-14-24 03:57AM
Mar-13-24 08:21AM
11:50PM
Loading…
Mar-06-24 11:50PM
Mar-05-24 05:00PM
10:07AM
Mar-04-24 06:19AM
Feb-29-24 04:15PM
Feb-23-24 05:43AM
Feb-21-24 07:07PM
04:00PM
Feb-17-24 03:32AM
Feb-15-24 07:41AM
02:18PM
Loading…
Feb-13-24 02:18PM
Feb-12-24 06:15PM
Feb-09-24 05:03PM
10:43AM
12:31AM
(Thomson Reuters StreetEvents)
12:14AM
Feb-08-24 12:06PM
11:05AM
09:30AM
08:40AM
08:27AM
07:50AM
(Associated Press Finance)
07:38AM
07:15AM
Feb-05-24 09:16AM
08:52AM
Loading…
08:52AM
Jan-04-24 04:15PM
Dec-22-23 09:00AM
Dec-15-23 10:45PM
01:28PM
Dec-14-23 08:00AM
08:00AM
07:42AM
Dec-13-23 04:30PM
Dec-11-23 07:58PM
04:22PM
09:00AM
Dec-04-23 08:00AM
Nov-28-23 09:00AM
Nov-22-23 04:01PM
Nov-14-23 04:30PM
10:03AM
Nov-07-23 08:00AM
Nov-06-23 08:30AM
Nov-04-23 01:24PM
Nov-03-23 01:12AM
12:37AM
(Thomson Reuters StreetEvents)
Nov-02-23 10:30PM
03:02PM
10:56AM
09:04AM
08:47AM
07:35AM
(Associated Press Finance)
07:15AM
07:11AM
Nov-01-23 06:27PM
07:46AM
Oct-30-23 11:40AM
08:18AM
Oct-24-23 02:18AM
Oct-23-23 09:15AM
Oct-18-23 10:57AM
03:00AM
Oct-16-23 11:36AM
09:00AM
Oct-11-23 06:49PM
03:57PM
(The Wall Street Journal)
03:38PM
12:03PM
11:52AM
11:33AM
10:45AM
Oct-03-23 09:00AM
Sep-29-23 06:01PM
Sep-21-23 06:55PM
Sep-19-23 04:15PM
Sep-12-23 08:43AM
Sep-07-23 01:44PM
07:00AM
Aug-31-23 12:32PM
Aug-29-23 04:15PM
Aug-24-23 08:30AM
Aug-22-23 04:15PM
10:02AM
Aug-21-23 05:00PM
Aug-14-23 07:02PM
Aug-11-23 10:28AM
Aug-05-23 08:10AM
Jul-31-23 10:24AM
09:59AM
Jul-27-23 11:32AM
11:28AM
10:13AM
09:30AM
09:05AM
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. The Americas, EMEA, and APAC segments offer a portfolio of essential healthcare products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and equipment for the surgical space. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Mason Jeanne K EVP, Chief HR Officer Mar 01 '24 Option Exercise 37.17 64,488 2,397,019 206,778 Mar 05 04:15 PM Mason Jeanne K EVP, Chief HR Officer Mar 01 '24 Sale 40.61 64,488 2,618,858 142,290 Mar 05 04:15 PM
Index S&P 500
P/E 13.02
EPS (ttm) 2.67
Insider Own 0.75%
Shs Outstand 229.78M
Perf Week 4.01%
Market Cap 7.98B
Forward P/E 7.94
EPS next Y 4.37
Insider Trans -14.30%
Shs Float 228.06M
Perf Month 12.87%
Income 625.00M
PEG 1.19
EPS next Q 0.88
Inst Own 98.79%
Short Float 5.10%
Perf Quarter -3.07%
Sales 15.84B
P/S 0.50
EPS this Y 4.34%
Inst Trans -1.23%
Short Ratio 3.95
Perf Half Y -12.71%
Book/sh 25.36
P/B 1.37
EPS next Y 11.77%
ROA 4.18%
Short Interest 11.64M
Perf Year -17.15%
Cash/sh 6.68
P/C 5.20
EPS next 5Y 10.90%
ROE 10.07%
52W Range 29.51 - 47.05
Perf YTD -3.10%
Dividend Est. 0.55 (1.58%)
P/FCF 16.73
EPS past 5Y -9.71%
ROI 6.48%
52W High -26.16%
Beta 1.31
Dividend TTM 0.50 (1.44%)
Quick Ratio 1.30
Sales past 5Y 8.00%
Gross Margin 18.49%
52W Low 17.72%
ATR (14) 0.77
Dividend Ex-Date Feb 29, 2024
Current Ratio 1.65
EPS Y/Y TTM -32.93%
Oper. Margin 8.89%
RSI (14) 70.86
Volatility 2.16% 2.29%
Employees 39900
Debt/Eq 0.67
Sales Y/Y TTM 0.27%
Profit Margin 3.94%
Recom 1.95
Target Price 39.24
Option/Short Yes / Yes
LT Debt/Eq 0.66
EPS Q/Q -39.38%
Payout 21.00%
Rel Volume 1.21
Prev Close 34.70
Sales Surprise -2.59%
EPS Surprise -4.77%
Sales Q/Q -14.26%
Earnings Feb 08 BMO
Avg Volume 2.95M
Price 34.74
SMA20 7.44%
SMA50 7.34%
SMA200 -6.81%
Trades
Volume 3,562,177
Change 0.12%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-15-24 Initiated
Piper Sandler
Overweight
$43
Feb-20-24 Downgrade
Exane BNP Paribas
Outperform → Neutral
$43 → $35
Jan-03-24 Downgrade
Robert W. Baird
Outperform → Neutral
$45 → $39
Nov-16-23 Upgrade
Guggenheim
Neutral → Buy
$41
Nov-03-23 Downgrade
Deutsche Bank
Buy → Hold
$47 → $36
Sep-13-23 Initiated
UBS
Buy
$52
Aug-17-23 Downgrade
Nomura
Buy → Neutral
$44
Jul-06-23 Upgrade
BofA Securities
Neutral → Buy
$54 → $67
May-15-23 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$49 → $50
Feb-15-23 Initiated
Barclays
Overweight
$62
Jan-09-23 Downgrade
BofA Securities
Buy → Neutral
$78 → $50
Dec-07-22 Upgrade
Exane BNP Paribas
Neutral → Outperform
$49
Nov-28-22 Upgrade
Morgan Stanley
Underweight → Equal-Weight
$35 → $45
Jul-18-22 Upgrade
Deutsche Bank
Hold → Buy
$43 → $48
Apr-11-22 Initiated
Exane BNP Paribas
Neutral
Sep-20-21 Downgrade
Jefferies
Buy → Hold
$65 → $47
Mar-26-21 Initiated
Wells Fargo
Overweight
$64
Nov-12-20 Downgrade
Wolfe Research
Outperform → Peer Perform
Nov-09-20 Downgrade
Morgan Stanley
Equal-Weight → Underweight
$27
Nov-04-20 Resumed
Goldman
Neutral
$36
Show Previous Ratings
Mar-28-24 06:15PM
02:36PM
09:00AM
Mar-27-24 08:15AM
Mar-24-24 10:42AM
06:15PM
Loading…
Mar-22-24 06:15PM
Mar-21-24 04:15PM
09:30AM
Mar-15-24 06:00PM
Mar-14-24 06:15PM
Mar-12-24 06:36AM
Mar-08-24 06:00PM
05:51AM
Mar-06-24 09:00AM
Mar-05-24 09:30AM
08:00AM
Loading…
Mar-01-24 08:00AM
Feb-29-24 04:10AM
03:12AM
Feb-26-24 01:48PM
Feb-22-24 07:53PM
Feb-15-24 11:34PM
Feb-14-24 09:00AM
Feb-09-24 04:22PM
11:15AM
09:38AM
06:23AM
02:35AM
(Thomson Reuters StreetEvents)
Feb-08-24 11:37AM
09:30AM
08:55AM
08:00AM
Loading…
08:00AM
08:00AM
08:00AM
07:45AM
07:11AM
07:04AM
06:55AM
(Associated Press Finance)
06:30AM
06:30AM
06:30AM
Feb-06-24 08:04AM
07:47AM
Feb-05-24 10:00AM
09:16AM
Feb-01-24 06:00PM
04:15PM
10:00AM
Jan-26-24 06:00PM
Jan-24-24 10:00AM
Jan-23-24 06:15PM
Jan-22-24 12:10PM
Jan-17-24 06:15PM
Jan-12-24 08:28AM
Jan-10-24 06:15PM
06:00AM
Jan-04-24 06:15PM
Jan-03-24 04:15PM
Dec-28-23 06:15PM
Dec-19-23 06:00PM
Dec-18-23 06:15PM
09:04AM
Dec-07-23 09:00AM
Dec-06-23 09:00AM
Dec-05-23 08:00AM
Dec-01-23 02:00AM
Nov-16-23 09:54AM
Nov-09-23 06:30AM
Nov-03-23 11:11AM
02:40AM
(Thomson Reuters StreetEvents)
Nov-02-23 11:06PM
(Morningstar Research) -13.07%
10:34AM
09:56AM
09:30AM
08:00AM
08:00AM
08:00AM
07:39AM
07:08AM
06:41AM
(Associated Press Finance)
06:30AM
Nov-01-23 11:13AM
Oct-27-23 10:21AM
Oct-26-23 04:15PM
10:02AM
Oct-24-23 06:00PM
12:06PM
09:00AM
08:15AM
12:00AM
Oct-23-23 06:15PM
Oct-17-23 06:15PM
Oct-11-23 06:15PM
Oct-05-23 06:15PM
Sep-30-23 12:09PM
Sep-29-23 06:15PM
02:25AM
Sep-22-23 06:15PM
11:33AM
Sep-20-23 04:15PM
Sep-15-23 06:00PM
BorgWarner, Inc. engages in the provision of technology solutions for combustion, hybrid and electric vehicles. It operates through the following segments: Air Management, Drivetrain & Battery Systems, and ePropulsion. The Air Management segment includes technologies, such as turbochargers, eBoosters, eTurbos, timing systems, emissions systems, thermal systems, gasoline ignition technology, smart remote actuators, powertrain sensors, cabin heaters, battery heaters, battery charging, and direct current charging stations. The Drivetrain & Battery Systems segment consists of battery modules and systems, control modules, friction and mechanical clutch products for automatic transmissions, torque-management products and rear-wheel drive (RWD), and all-wheel drive (AWD) transfer case systems and coupling systems. The ePropulsion segment focuses on power electronics, such as inverters, onboard chargers, DC/DC converters, and combination boxes. The company was founded in 1928 and is headquartered in Auburn Hills, MI.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Demmerle Stefan Vice President Mar 13 '24 Sale 33.00 3,000 99,000 249,013 Mar 14 05:01 PM Weng Volker Vice President Mar 07 '24 Sale 32.85 20,000 657,000 111,964 Mar 08 04:05 PM Demmerle Stefan Vice President Mar 05 '24 Sale 31.29 3,000 93,877 252,013 Mar 06 04:11 PM Lissalde Frederic President and CEO Feb 14 '24 Sale 31.08 225,900 7,021,582 455,227 Feb 15 04:28 PM CALAWAY TONIT M EVP, CAO, Gen Counsel & Sec Feb 12 '24 Sale 32.15 35,603 1,144,508 83,348 Feb 12 04:57 PM Demmerle Stefan Vice President Jun 14 '23 Sale 47.61 5,000 238,050 177,614 Jun 15 10:45 AM Fadool Joseph F. Vice President May 30 '23 Sale 46.70 210 9,818 0 May 31 05:56 PM Fadool Joseph F. Vice President May 26 '23 Sale 47.16 631 29,744 210 May 30 03:45 PM MICHAS ALEXIS P Director May 17 '23 Sale 44.45 7,173 318,851 76,441 May 18 06:05 AM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite